LifeScience Biologics
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has sig...
September 22, 2022 | News
Thermo Fisher unveils $160M bioprocessing facility in greater Boston
Thermo Fisher Scientific Inc., the world leader in serving science, today opened a new biomanufacturing facility in Chelmsford, Massachusetts. Th...
September 21, 2022 | News
Biocytogen Announces Collaboration with FineImmune to Develop TCR-Mimic Antibody-based Cell Therapy
Biocytogen’s TCR-mimic antibody development platform utilizes its proprietary fully human antibody RenMice™ (RenMab™ and RenLite®&nbs...
September 19, 2022 | News
Juniper Biologics Establishes Global Headquarters in Singapore
Juniper Biologics, a science-led speciality healthcare company focused on commercialising novel therapies, today announced the establishment of its Global ...
September 15, 2022 | News
Gilead Sciences Celebrates Top Ranking By Hepatitis and Asian Patient Groups
Gilead also ranks first among peers in Asia by patient groups in this region -- Gilead Sciences, Inc. ranks first among peers for over...
September 15, 2022 | News
DLA Piper attends signing ceremony for exclusive strategic collaboration with Beijing E-town
Beijing E-town Bio Park is located in Beijing Economic and Technological Development Zone and has attracted close to 200 prestigious life science enterpris...
September 13, 2022 | News
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio
The award will fund the continued advancement of the company's proprietary PANDAA™ technology platform and its specific application to the univ...
September 13, 2022 | News
Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive early data for two novel and investigational bispecific antibodies – uba...
September 12, 2022 | News
Jacobio Completes First Patient Dosage of CD73 mAb JAB-BX102 in China
This is a phase I/IIa multi-center, open-label clinical study to evaluate the safety, tolerability, pharmacokinetics, and preliminary evidence of anti-tumo...
September 05, 2022 | News
Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East
Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...
September 02, 2022 | News
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...
September 01, 2022 | News
Biocytogen Expands Partnership with Merck
Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...
August 29, 2022 | News
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi t...
August 29, 2022 | News
Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies
Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...
August 25, 2022 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
